Cancer - breast news and cancer - breast widget

An Indiana University study found that young, female breast cancer survivors often suffer from sexual and intimate relationship issues and are interested in using sexual enhancement products to treat these problems. The study, "Young Female Breast Cancer Survivors: Their sexual function and interest in sexual enhancement products and services," was published Nov. 4 in the journal Cancer Nursing.

Ikonisys, a leading provider of next generation, non-invasive, cell-based diagnostic solutions, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its oncoFISH her2 test. oncoFISH her2 is a fully automated microscopy application for the determination of HER2 status in human breast cancer specimens processed with Abbott's PathVysion(R) HER2 DNA Probe Kit. The test runs on the company's proprietary CellOptics(R) platform, featuring the Ikoniscope(R), a proprietary high-throughput, digital microscope, and provides "walk-away" automated testing of the HER2 gene to provide an early and accurate indication for gene amplification. Breast cancer is one of the most common types of cancer in women in the...